EPISODE · Oct 25, 2023 · 1H 11M
TechBio Founders #24: Using AI and multi-omics to predict the efficacy of immunotherapies with Vadim Nazarov, CEO at ImmunoMind
from Next Sequence · host Vadim Nazarov, Loretta TIOIELA
ImmunoMind is a UC Berkeley SkyDeck alumnus company. ImmunoMind helps biotech companies understand crucial drug-human interactions, and transform the biodata chaos into more effective immunotherapies.
Embed this episode
NOW PLAYING
TechBio Founders #24: Using AI and multi-omics to predict the efficacy of immunotherapies with Vadim Nazarov, CEO at ImmunoMind
0:00
1:11:51
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of Next Sequence?
This episode is 1 hour and 11 minutes long.
When was this Next Sequence episode published?
This episode was published on October 25, 2023.
Can I download this Next Sequence episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!